Mutations in IDH1 occur in 7.8–16% of patients with cytogenetically normal (CN) AML (CN-AML), and IDH2 mutations, in 10–19% of those with CN-AML [75, 76, 78]. The gene discussed is IDH2; the disease is acute myeloid leukemia.